secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001185185-25-002055
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma increases authorized common stock from 150M to 600M shares
---------------------------------------------------------------------

- Amendment effective Dec 12, 2025, after stockholder approval on Oct 10, 2025.
- Authorized common stock raised from 150M to 600M shares; preferred stock unchanged at 1M shares.
- Total authorized shares (all classes) increased from 151M to 601M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525002055/0001185185-25-002055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525002055/igc8k121525.htm
  HTML page:      https://secwatch.observer/filing/0001185185-25-002055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer